A Study of LY4175408 in Participants With Advanced Cancer
Eli Lilly and Company
Eli Lilly and Company
Kivu Bioscience Inc.
Mersana Therapeutics
National Cancer Institute (NCI)
Eli Lilly and Company
Exscientia AI Limited
Epsilogen Ltd
Arcus Biosciences, Inc.
IDEAYA Biosciences
Sotio Biotech Inc.
Eli Lilly and Company
National Cancer Institute (NCI)
Rondo Therapeutics
Atavistik Bio, Inc
Merck Sharp & Dohme LLC
NiKang Therapeutics, Inc.
Alterome Therapeutics, Inc.
BeOne Medicines
Accent Therapeutics
Seagen Inc.
Tizona Therapeutics, Inc
Normunity AccelCo, Inc.
NiKang Therapeutics, Inc.
Institute of Cancer Research, United Kingdom
SystImmune Inc.
Eli Lilly and Company
Seagen Inc.
Fusion Pharmaceuticals Inc.
Innate Pharma
Dren Bio
Novartis
M.D. Anderson Cancer Center
OncoNano Medicine, Inc.
NeoTX Therapeutics Ltd.
Bolt Biotherapeutics, Inc.
Nuvation Bio Inc.
NiKang Therapeutics, Inc.
Nurix Therapeutics, Inc.
Exelixis
Adcentrx Therapeutics
Xencor, Inc.
Numab Therapeutics AG
Incyte Corporation
Lyell Immunopharma, Inc.
NextPoint Therapeutics, Inc.
M.D. Anderson Cancer Center
Monopar Therapeutics
Monopar Therapeutics
Theratechnologies
Exelixis